
Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.
The company cites 14% organic sales growth.
DSM (Heerlen, Switzerland) reports strong Q3 performance, citing 14% organic sales growth. The company says that its nutrition division continues to perform well, with its acquisition of Martek Biosciences having “excellent performance that clearly exceeded expectations.” DSM reports the acquisition as successfully completed.






